Riskpilot← Back to searchSign inGet full accessNordic Life Sciences A/S
A/SActiveCVR 41727659Langehede 103AManufacture of basic pharmaceutical products · NACE 2110Est. 20202 employees
Revenue 2025
DKK -8,9M
-16% vs 2024
EBITDA margin
131.1%
+15% vs 2024
Equity ratio
-208.1%
Financial strength
Net profit 2025
DKK -9,3M
+16% vs 2024
| Revenue | DKK -8,9M | -16% |
| EBITDA | DKK -11,6M | +15% |
| Net profit | DKK -9,3M | +16% |
| Total assets | DKK 6,7M | -5% |
| Equity | DKK -13,9M | +30% |
| Employees | 2 | — |
Legal name
Nordic Life Sciences A/S
CVR number
41727659
Legal form
Aktieselskab
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
24. september 2020
Share capital
DKK 466.945
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er at drive forretning med at dyrke medicinsk cannabis, fremstille og markedsføre medicinske cannabisbaserede produkter til EUDRA GMP standarder under licens fra de danske myndigheder samt al virksomhed, som efter direktionens skøn er beslægtet hermed.
Address
Langehede 103A
Phone
+4561487784
Email
info@realcannaseeds.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -1.050 | -2.427 | -4.004 | -10.527 | -8.873 |
| Staff expenses | -0 | -2.556 | -1.223 | -3.198 | -2.759 |
| EBITDA | -1.050 | -4.983 | -5.228 | -13.726 | -11.632 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -31 |
| EBIT | -1.050 | -4.983 | -5.228 | -13.726 | -11.663 |
| Net financials | 0 | -21 | -20 | -50 | 35 |
| Profit before tax | -1.050 | -5.004 | -5.247 | -13.775 | -11.628 |
| Tax | -0 | -0 | -1.975 | -2.725 | -2.328 |
| Net profit | -1.050 | -5.004 | -3.272 | -11.050 | -9.300 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 0 | 3.321 | 2.628 | 7.062 | 6.689 |
| Equity | -1.010 | -6.014 | -8.927 | -19.975 | -13.918 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.010 | 9.336 | 11.555 | 27.037 | 20.607 |
| Total debt | 1.010 | 9.336 | 11.555 | 27.037 | 20.607 |
EBITDA margin
-1163190900.0%
This company
15.8%
Market median
-7361967822% vs market
20212025
Equity ratio
-208.1%
This company
38.2%
Market median
-645% vs market
20212025
Return on equity
-929971600.0%
This company
18.4%
Market median
-5054193578% vs market
20212025
Net profit margin
-929971600.0%
This company
8.1%
Market median
-11481130964% vs market
20212025
Asset turnover
-1.33×
This company
1.12×
Market median
-219% vs market
20212025
Debt / equity
1.48×
This company
0.62×
Market median
-139% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-09-24 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RC Founder | Founder | 2020 |
ES Management | Management | 2025 |
| Former (2) | ||
AR Management | Management | 2022 – 2025 |
JS Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2025 – 2025 | |
| Board of Directors | 2024 – 2026 | |
| Chairman | 2025 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 15–19.99% | 15–19.99% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nordic Life Sciences A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Raft | Management | 0 companies |
| Real Canna Seeds Limited | Founder | 0 companies |
| Janus Sebastian Nielsen | Chief Executive Officer | 0 companies |
| Erik Sundt | Management | 0 companies |
| Rime Bahij | Board of Directors | 0 companies |
| Jan Hans Mikael Jönsson | Board of Directors | 0 companies |
| Pål Anders Nordvi | Board of Directors | 0 companies |
| Kjell Roland Adstedt | Chairman | 0 companies |